These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12626750)

  • 21. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
    Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
    J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of radioiodinated acridine derivatives for in vivo imaging of prion deposits in the brain.
    Kawasaki M; Fuchigami T; Kobashi N; Nakagaki T; Sano K; Atarashi R; Yoshida S; Haratake M; Nishida N; Nakayama M
    Bioorg Med Chem; 2017 Feb; 25(3):1085-1093. PubMed ID: 28041803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
    J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous quinacrine treatment results in the formation of drug-resistant prions.
    Ghaemmaghami S; Ahn M; Lessard P; Giles K; Legname G; DeArmond SJ; Prusiner SB
    PLoS Pathog; 2009 Nov; 5(11):e1000673. PubMed ID: 19956709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
    Rambold AS; Miesbauer M; Olschewski D; Seidel R; Riemer C; Smale L; Brumm L; Levy M; Gazit E; Oesterhelt D; Baier M; Becker CF; Engelhard M; Winklhofer KF; Tatzelt J
    J Neurochem; 2008 Oct; 107(1):218-29. PubMed ID: 18691383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
    Daude N; Marella M; Chabry J
    J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
    Allard EK; Grujic M; Fisone G; Kristensson K
    Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of prion propagation by dehydrocholesterol reductase inhibitors in cultured cells and a therapeutic trial in mice.
    Hagiwara K; Nakamura Y; Nishijima M; Yamakawa Y
    Biol Pharm Bull; 2007 Apr; 30(4):835-8. PubMed ID: 17409533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I; Cardinale A; Mattei S; Biocca S
    J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Prion Screening for Acridine, Dextran, and Tannic Acid using Real Time-Quaking Induced Conversion: A Comparison with PrPSc-Infected Cell Screening.
    Hyeon JW; Kim SY; Lee SM; Lee J; An SS; Lee MK; Lee YS
    PLoS One; 2017; 12(1):e0170266. PubMed ID: 28095474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and cytotoxic evaluation of N1,Nm-bis[(tetrahydrobenzo[a]acridin-12-yl)phenyl]alkanediamides and N1,Nm-bi.
    Martínez R; Cogordan JA; Mancera C; Díaz MA
    Farmaco; 2000; 55(9-10):631-6. PubMed ID: 11152245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
    Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis.
    Schonberger O; Horonchik L; Gabizon R; Papy-Garcia D; Barritault D; Taraboulos A
    Biochem Biophys Res Commun; 2003 Dec; 312(2):473-9. PubMed ID: 14637161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
    Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of prion propagation by enantiomers of quinacrine.
    Ryou C; Legname G; Peretz D; Craig JC; Baldwin MA; Prusiner SB
    Lab Invest; 2003 Jun; 83(6):837-43. PubMed ID: 12808118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.